Breaking through innovation and cracking down on growth troubles
New Coronary Pneumonia continues to spread, constantly challenging the stability of the pharmaceutical supply chain. At the same time, it also makes the global pharmaceutical industry chain and supply chain "tighter", and the new international connotation of Chinese medicine. In a special period, we examine the past and present, and we still need to explore the possibilities of the next decade.
After decades of ups and downs, from lack of medicines and drugs to self-sufficiency, to the rapid growth of China's pharmaceutical industry with the reform and opening up, a batch of raw materials, preparations and medical equipment have passed international certification, and the scope of export varieties has continued to expand and technology With the content continually escalating, China has leapt to become the world's largest producer and exporter of APIs.